Search Results 621-630 of 17084 for hla genotype
The purpose of this study is to identify novel genetic variants that predispose to Type 1 Diabetes. Participation eligibility. Participant eligibility includes ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL.
All allogeneic donor sources are permitted, including siblings, unrelated donors, human leukocyte antigen (HLA)-haploidentical related donors and umbilical cord ...
This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance ...
Galldiks N, Lohmann P, Werner JM, Felder J, Hu LS, Kaufmann TJ. Point/counterpoint: The use of perfusion-weighted MRI and amino acid PETfor the ...
Also called Osler-Weber-Rendu disease and HHT, hereditary hemorrhagic telangiectasia passes from parents to children. How bad it is can vary greatly from person ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
The purpose of this study is to obtain more detailed information about bone structure in adults with repeat bone fractures. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!